Back

Ezetimibe use and mortality after myocardial infarction: a nationwide cohort study

31 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Novel and old treatments, evidence in large populations Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ville Kyto

Turku University Hospital, Turku (Finland)

7 More presentations in this session

Presentation thumbnail
Lipid-lowering therapy with Inclisiran in the real-world setting: initial data from a national health care service
Associate Professor B. Zafrir (Haifa, IL)
Abstract Slides Video
Presentation thumbnail
Moderate-intensity statin combined with ezetimibe versus high-intensity statin monotherapy for secondary cardiovascular risk reduction: a systematic review and meta-analysis
Mr M. Kritya (Pune, IN)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of intravenous iron therapy in heart failure patients with iron deficiency: a systematic review and meta-analysis of randomized controlled trials
Doctor M. Abouzid (Poznan, PL)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of guideline-directed medical therapy in functional mitral regurgitation: a meta-analysis
Doctor V. Anastasiou (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Temporal trends and regional differences of initial oral antiarrhythmic drug options in patients with new-onset atrial fibrillation: a report from the GLORIA-AF registry
Mr B. Huang (Chongqing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Novel and old treatments, evidence in large populations

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Association of lipid-lowering drug treatment with all-cause and cardiovascular mortality among people aged 75 years and above without cardiovascular disease: evidence from a cohort study
thumbnail
Congress Presentation
MI-TRAJECTORY - Subsequent cardiovascular disease trajectories following myocardial infarction
thumbnail
Congress Presentation
Lipid-lowering therapy is associated with lower mortality in heart failure patients: Insights from Swedish national registries data from 2006 to 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources